Inventor · disambiguated record
Chi-Hsin Richard King
Also filed as: KING CHI-HSIN R · KING CHI-HSIN RICHARD
29 granted patents·13 pending applications·209 citations·filing 1986–2020
96Inventor score
Files withMERRELL PHARMA INC12TAIGEN BIOTECHNOLOGY CO LTD12AVENTIS PHARMA INC3YEN CHI-FENG3BIOLITE INC2
Top patents by PatentIndex Score
42 records- 0190US10004719B1Solid dispersion formulationTAIGEN BIOTECHNOLOGY CO LTD·Filed 2017·Granted Jun 26, 2018·12 cites·29 claims
- 0287US8193206B2Pyrimidine compoundsYEN CHI-FENG·Filed 2008·Granted Jun 5, 2012·9 cites·15 claims
- 0384US5631375AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted May 20, 1997·26 cites·2 claims
- 0482US5654433AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Aug 5, 1997·29 cites·3 claims
- 0581US7589197B2Pyrimidine compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2006·Granted Sep 15, 2009·7 cites·8 claims
- 0680US8372849B2Heterocyclic compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Granted Feb 12, 2013·5 cites·10 claims
- 0779US5675009AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Oct 7, 1997·15 cites·3 claims
- 0878US5644061AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Jul 1, 1997·14 cites·5 claims
- 0977US7405299B2Compounds as pharmaceutical agentsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·15 cites·1 claims
- 1077US5618940AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Apr 8, 1997·13 cites·1 claims
- 1176US5652370AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Jul 29, 1997·13 cites·9 claims
- 1276US5650516AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Jul 22, 1997·13 cites·5 claims
- 1374US5663353AProcess for piperidine derivativesMERRELL PHARMA INC·Filed 1995·Granted Sep 2, 1997·11 cites·3 claims
- 1469US9375406B2Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptorTAIGEN BIOTECHNOLOGY CO LTD·Filed 2014·Granted Jun 28, 2016·1 cites·10 claims
- 1569US8389560B2HCV protease inhibitorsLIU CHEN-FU·Filed 2009·Granted Mar 5, 2013·2 cites·28 claims
- 1669US8211909B2Treatment of antibiotic-resistant bacteria infectionHSU MING-CHU·Filed 2008·Granted Jul 3, 2012·2 cites·12 claims
- 1769US6716986B2Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2-methoxy-phenyl]esterAVENTIS PHARMA INC·Filed 2002·Granted Apr 6, 2004·3 cites·14 claims
- 1868US9023834B2Lyophilization formulationYEN CHI-FENG·Filed 2009·Granted May 5, 2015·2 cites·26 claims
- 1962US2004152900A1Method for the isolation of sulfuric acid mono-[3({1-[2-(4-fluorophenyly)-ethyl]-piperidin-4-yl}-2-methoxy-phenyl}esterAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 2061US8658183B2Antimicrobial parenteral formulationLEE LIH-HUEI·Filed 2007·Granted Feb 25, 2014·2 cites·27 claims
- 2159US2009227798A1Novel processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanolSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Application pending·0 cites
- 2255US5869475ACertain 3-ketosteroids used to inhibit steroid 5α-reductaseMERRELL PHARMA INC·Filed 1997·Granted Feb 9, 1999·8 cites·2 claims
- 2352US6465490B1Sulfuric acid mono-[3({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]esterAVENTIS PHARMA INC·Filed 2000·Granted Oct 15, 2002·3 cites·86 claims
- 2449US2005261341A1Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanolAVENTIS PHARMA GMBH·Filed 2005·Application pending·0 cites
- 2549US2010152452A1Stereoselective synthesis of piperidine derivativesTAIGEN BIOTECHNOLOGY CO LTD·Filed 2009·Application pending·0 cites
- 2648US11857592B2Polygala extract for the treatment of attention-deficit hyperactivity disorderBIOLITE INC·Filed 2020·Granted Jan 2, 2024·0 cites·4 claims
- 2747US11554154B2Polygala extract for the treatment of major depressive disorderBIOLITE INC·Filed 2020·Granted Jan 17, 2023·0 cites·11 claims
- 2847US4803278APreparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-onesMERRELL DOW PHARMA·Filed 1986·Granted Feb 7, 1989·2 cites·5 claims
- 2946US7504422B2Polyamine compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2007·Granted Mar 17, 2009·0 cites·33 claims
- 3046US2009214529A9Kinesin inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Application pending·0 cites
- 3146US2010041697A1Pneumonia treatmentTAIGEN BIOTECHNOLOGY CO LTD·Filed 2009·Application pending·0 cites
- 3243US2008108632A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2007·Application pending·0 cites
- 3343US2009286814A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Application pending·0 cites
- 3443US2012157492A1Antibiotic drugHSU MING-CHU·Filed 2009·Application pending·0 cites
- 3541US2009111757A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Application pending·0 cites
- 3641US2008242861A1Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivativesYEN CHI-FENG·Filed 2007·Application pending·0 cites
- 3739US5750744AProcess for the preparation of 4-amino- 4-3-ketosteroids via 4-nitro- 4-3-ketosteroidsMERRELL PHARMA INC·Filed 1995·Granted May 12, 1998·2 cites·2 claims
- 3839US2008207528A1Hcv protease inhibitorsYANG SYAULAN·Filed 2008·Application pending·0 cites
- 3934US2011178107A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2011·Application pending·0 cites
- 4032US5990328AProcess for the preparation of 4-amino-Δ4-3-ketosteroids via 4-nitro-Δ4-3-ketosteroidsMERRELL PHARMA INC·Filed 1999·Granted Nov 23, 1999·0 cites·21 claims
- 4131US5965550AProcess for the preparation of 4-amino-Δ4 -3-ketosteroids via 4-nitro-Δ4 -3-ketosteroidsMERRELL PHARMA INC·Filed 1998·Granted Oct 12, 1999·0 cites·4 claims
- 4231US5766932AProcess for preparing N-acetyl(L)-4-cyanophenylalanine from a mixture of the corresponding D,L ethyl esters using subtilisinHOECHST MARION ROUSSEL INC·Filed 1996·Granted Jun 16, 1998·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Chi-Hsin Richard King files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →